InvestorsObserver
×
News Home

Is Selecta Biosciences Inc (SELB) the Top Pick in the Biotechnology Industry?

Friday, October 16, 2020 09:49 AM | InvestorsObserver Analysts

Mentioned in this article

Is Selecta Biosciences Inc (SELB) the Top Pick in the Biotechnology Industry?

Selecta Biosciences Inc (SELB) is near the middle in its industry group according to InvestorsObserver. SELB gets an overall rating of 48. That means it scores higher than 48 percent of stocks. Selecta Biosciences Inc gets a 51 rank in the Biotechnology industry. Biotechnology is number 27 out of 148 industries.

Overall Score - 48
SELB has an Overall Score of 48. Find out what this means to you and get the rest of the rankings on SELB!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Selecta Biosciences Inc Stock Today?

Selecta Biosciences Inc (SELB) stock is trading at $2.30 as of 9:46 AM on Friday, Oct 16, a rise of $0.19, or 8.79% from the previous closing price of $2.11. The stock has traded between $2.20 and $2.31 so far today. Volume today is below average. So far 223,208 shares have traded compared to average volume of 2,413,171 shares.

Click Here to get the full Stock Score Report on Selecta Biosciences Inc (SELB) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App